Exalt Clinical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obstructive sleep apnoea4 trials
• Psoriasis2 trials

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed4 trials
• Recruiting2 trials

Lead sponsor

• Incannex Healthcare Ltd2 trials
• Alumis Inc1 trial
• Apnimed1 trial
• Resvent Holding USA LTD1 trial
• Takeda1 trial

Running trials

• Recruiting

  DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

  NCT07635563· Phase 2· Incannex Healthcare Ltd· Source

  Contact: Tiffany Hecklinski, PhD

• Recruiting

  A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

  NCT07250802· Phase 3· Takeda· Source

  Contact: Jaqueline McKesey (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obstructive sleep apnoea1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· Phase 3· Alumis Inc· Source

• Completed

  RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

  NCT06146101· Phase 2/3· Incannex Healthcare Ltd· Source

• Completed

  Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

  NCT05813275· Phase 3· Apnimed· Source

• Completed

  Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

  NCT06008678· Resvent Holding USA LTD· Source